Prospective determination of perioperative Risk of pancreatioduodenectomy after neoadjuvant stereotactic radiotherapy of pancreatic cancer
Not Applicable
- Conditions
- C25.0Head of pancreas
- Registration Number
- DRKS00019011
- Lead Sponsor
- niversitätsklinikum Freiburg, Departemnt Chirurgie, Klinik für Allgemein- und Viszeralchirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
Patients with histologically proven resectable ductal adenocarcinoma and ability to give written informed consent
Exclusion Criteria
Participation in trial interfering with the trial
Infiltration of stomach or intestine
Pregnancy and breast feeding
Risk of incompliance
Unwillingness or inability to perform birth control
Bilirubin > 2.5 x upper reference value
Clinically relevant duodenal stenosis
renal insufficiency with GRF<30
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of severe complications within 6 weeks after radiotherapy and surgery
- Secondary Outcome Measures
Name Time Method 30 day mortality